Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
0.8599
-0.0401 (-4.46%)
Oct 10, 2025, 1:23 PM EDT - Market open
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $108.61 million as of October 10, 2025. Its market cap has decreased by -71.32% in one year.
Market Cap
108.61M
Enterprise Value
-6.02M
1-Year Change
-71.32%
Ranking
Category
Stock Price
$0.86
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has decreased from $117.04M to $108.61M, a decrease of -7.20%. That is a compound annual growth rate of -1.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 113.67M | -46.11% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
| Mar 26, 2021 | 117.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 767.88B |
| Johnson & Johnson | 460.19B |
| AbbVie | 407.53B |
| UnitedHealth Group | 333.01B |
| AstraZeneca | 266.87B |
| Novo Nordisk | 261.06B |
| Novartis AG | 256.06B |
| Abbott Laboratories | 232.02B |